These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 669547)

  • 21. In vitro susceptibility of Yersinia kristensenii strains to beta-lactam antibiotics.
    Bejar V; Calvo C; Ramos Cormenzana A
    Ann Inst Pasteur Microbiol (1985); 1986; 137A(2):169-77. PubMed ID: 3501272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
    Neu HC; Chin NX
    Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A new method for evaluation of beta-lactamase production of resistant enterobacteriaceae strains (author's transl)].
    Schassan HH
    Zentralbl Bakteriol Orig A; 1978; 242(3):347-54. PubMed ID: 371259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [HR 756. In vitro microbiological activity against various species of anaerobic bacteria].
    Dainelli B; Filadoro F; Magni A; Maragoni F; Renzini G
    G Ital Chemioter; 1979; 26(1-2):141-4. PubMed ID: 554802
    [No Abstract]   [Full Text] [Related]  

  • 25. Anaerobic bacteria: evaluation of disc susceptibility to four cephalosporins.
    Dubois J; Pechère JC
    Infection; 1978; 6(6):266-70. PubMed ID: 730395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of cephalosporins by Bacteroides.
    Tally FP; O'Keefe JP; Sullivan NM; Gorbach SL
    Antimicrob Agents Chemother; 1979 Nov; 16(5):565-71. PubMed ID: 525995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bactericidal kinetics of cefazolin, cefoxitin and amikacin alone and in combination (author's transl)].
    Shah PM; Stille W
    Arzneimittelforschung; 1978; 28(9):1539-41. PubMed ID: 383106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro susceptibility of bacteroidaceae to cefoxitin and cephalothin (author's transl)].
    Werner H; Firsching R; Krasemann C
    Infection; 1977; 5(1):13-6. PubMed ID: 856727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cefazedone: microbiological evaluation in comparison with cephalothin and cefazolin.
    Wahlig H; Dingeldein E; Mitsuhashi S; Kawabe H
    Arzneimittelforschung; 1979; 29(2a):369-78. PubMed ID: 582712
    [No Abstract]   [Full Text] [Related]  

  • 32. Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic.
    Darland G; Birnbaum J
    Antimicrob Agents Chemother; 1977 Apr; 11(4):725-34. PubMed ID: 856025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbiological activity of cefazedone as compared to cefazolin and cephalothin.
    Knothe H
    Arzneimittelforschung; 1979; 29(2a):378-81. PubMed ID: 39575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of anaerobes to cefoxitin and other cephalosporins.
    Tally FP; Jacobus NV; Bartlett JG; Gorbach SL
    Antimicrob Agents Chemother; 1975 Feb; 7(2):128-32. PubMed ID: 1137364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies with cefuroxime and cefoxitin.
    Geddes AM; McGhie D; Ball AP; Gould I
    Scand J Infect Dis Suppl; 1978; (13):78-81. PubMed ID: 308260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of cephalosporin resistance in clinical isolates of Escherichia coli.
    Sawai T; Ando-Kuroda I; Murata T; Yamagishi S
    J Pharmacobiodyn; 1980 Jul; 3(7):364-6. PubMed ID: 7009827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro testing of newer cephalosporins (author's transl)].
    Linzenmeier G; Rosenthal E
    Infection; 1979; 7 Suppl 2():S225-7. PubMed ID: 437897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of four recently introduced cephalosporins with respect to probability of resistance in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. (author's transl)].
    Loch R; Schröter G
    Zentralbl Bakteriol Orig A; 1979; 245(3):312-6. PubMed ID: 44785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study of the "in vitro" sensitivity of cefoxitin and cephalosporins].
    Torres A; Aguirre M; Ales JM
    Rev Clin Esp; 1979 Nov; 155(4):249-52. PubMed ID: 542674
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
    Harper PB
    Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.